Related Experiment Videos

Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation

Mei Wan1, Xuesong Cao, Yalei Wu

  • 1Department of Pathology, University of Alabama at Birmingham School of Medicine, 1670 University Boulevard, VH G002, Birmingham, AL 35294-0019, USA.

EMBO Reports
|January 31, 2002
PubMed

Insights

Jab1 targets the tumor suppressor Smad4 for degradation, antagonizing transforming growth factor beta (TGF-beta) signaling. This novel pathway involves Jab1-induced ubiquitylation and proteasomal breakdown of Smad4.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Smad4 is a key mediator in transforming growth factor beta (TGF-beta) signaling, essential for gene transcription.
  • While Smurfs degrade regulatory Smads (R-Smads), Smad4 degradation mechanisms were previously unknown.

Purpose of the Study:

  • To elucidate a novel mechanism for Smad4 degradation.
  • To investigate the role of Jab1 in Smad4 regulation and TGF-beta signaling.

Main Methods:

  • Investigated the interaction between Jab1 and Smad4 using biochemical assays.
  • Assessed Smad4 ubiquitylation and degradation via proteasome inhibitors (lactacystin, MG132).
  • Quantified the impact of Jab1 on TGF-beta-induced gene transcription.

Main Results:

  • Jab1 directly interacts with Smad4, inducing its ubiquitylation and subsequent degradation by the 26S proteasome.
  • Ectopic Jab1 expression reduced endogenous Smad4 levels.
  • Jab1-mediated Smad4 degradation inhibited TGF-beta-induced gene transcription.

Conclusions:

  • Jab1 antagonizes TGF-beta signaling by promoting Smad4 degradation through a novel pathway.
  • This finding reveals a new mechanism controlling TGF-beta pathway activity and Smad4 stability.

Related Concept Videos